immunological

Uses pili-mediated gut adhesion and soluble immune factors to shorten infectious diarrhea in children and reduce antibiotic-associated diarrhea, with RCT and meta-analysis support.

Stimulates NK cell activity via IL-12 signaling to reduce upper respiratory tract infection risk, supported by multiple RCTs.

Stimulates immune components in breast milk to reduce infant infections, with RCT support.

Uses gut colonization and immune signaling to reduce infectious diarrhea in children and support gut barrier development, with RCT evidence.

Produces bacteriocin ABP-118 to inhibit pathogens and modulate mucosal immunity, with IBD model evidence.

Uses cell wall polysaccharides to modulate immunity and reduce IBS symptoms, with RCT evidence.

Consumes human milk oligosaccharides to produce anti-inflammatory metabolites, reducing IBS symptoms with RCT support.

Uses gut adhesion and bifidogenic metabolites to reduce antibiotic-associated diarrhea and support infant gut development, with RCT evidence.

Modulates gut transit time and immune cell activity to improve constipation and reduce infections, with RCT support.

Uses immune modulation to reduce allergic sensitization and respiratory symptoms in children, with RCT evidence.

Uses competitive pathogen exclusion and immune modulation to reduce infections and allergy symptoms, with RCT support.

Supports gut microbiome development in preterm infants as part of multi-strain formulations, with RCT evidence.

Uses spore germination in the small intestine and bile salt hydrolase activity to improve blood lipids and gut barrier function, with RCT evidence.

Uses immune modulation to reduce eczema prevalence through age 11 and improve postpartum mental health, with long-term RCT support.